Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome.

Journal of thrombosis and thrombolysis - 1 Oct 2008

Perunicic Jovan, Antonijevic Nebojsa M, Miljic Predrag, Djordjevic Valentina, Mikovic Danijela, Kovac Mirjana, Djokic Milan, Mrdovic Igor, Nikolic Aleksandra, Vasiljevic Zorana

Abstract excerpt

Treatment of patients with heparin-induced thrombocytopenia type II (HIT II) and thrombosis in some cases that represents a clinical challenge, which, if unrecognized, may lead to treatment delay or disease progression with potentially lethal outcome. We present a case of a 19-year-old patient wi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Anticoagulants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiphospholipid Syndrome

Share to Heparin

Share to Infusions, Intravenous

Share to Platelet Count

Share to Thrombocytopenia

Share to Venous Thromboembolism

Source

Identifiers

PMID: 17828468
DOI: 10.1007/s11239-007-0076-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17828468-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome.PMID 17828468Read ↗

An overview of the heparin-induced thrombocytopenia syndrome.Semantic proximity Read ↗

Heparin Induced Thrombocytopenia in Patients with COVID-19Semantic proximity Read ↗

Severe Cerebral Venous Sinus Thrombosis and Deep Vein Thrombosis Induced by Non-Criteria aPI and aPS/PT Positive Antiphospholipid Antibodies: A Case Report and Mini ReviewSemantic proximity Read ↗

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?Semantic proximity Read ↗

Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia.Semantic proximity Read ↗

[Deep vein thrombosis - diagnostics and clarification].Semantic proximity Read ↗

From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome.Semantic proximity Read ↗

2B or not 2B? A diagnosis of von Willebrand disease a lifetime of 86 years in the making.Semantic proximity Read ↗

Catastrophic Antiphospholipid Syndrome Presenting with Extensive Iliac Vein Thrombosis and Subsequent Takotsubo Cardiomyopathy in a Young WomanSemantic proximity Read ↗

Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar-Cases Series and a Review of the Literature.Semantic proximity Read ↗

[Thrombotic thrombocytopenic purpura].Semantic proximity Read ↗

Thrombotic thrombocytopenic purpura.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.